CLIPPERS as a differential diagnosis to multiple sclerosis: evidence from pathology and 7T MRI

Autor: Blaabjerg, Morten, Ruprecht, K, Sinnecker, T, Kondziella, D, Niendorf, T, Kern-Jespersen, BM, Lindelof, M, Lassmann, H, Kristensen, B.W., Paul, F, Illés, Zsolt

Publikováno v: Blaabjerg, M, Ruprecht, K, Sinnecker, T, Kondziella, D, Niendorf, T, Kern-Jespersen, BM, Lindelof, M, Lassmann, H, Kristensen, B W, Paul, F & Illés, Z 2015, ' CLIPPERS as a differential diagnosis to multiple sclerosis: evidence from pathology and 7T MRI ', 31th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Barcelona, Spain, 07/10/2015-10/10/2015 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::fc8e6f94342eda48bcda9de0e037aeb0
https://portal.findresearcher.sdu.dk/da/publications/72a56cbb-48dc-4604-a6a3-63c5431abd9f

The Effect of α-, β- and γ-Cyclodextrin on Wheat Dough and Bread Properties.

Autor: Jødal AS; Section of Chemistry, Department of Chemistry and Bioscience, Aalborg University, DK-9220 Aalborg, Denmark.; Lantmännen Unibake Denmark, DK-8700 Horsens, Denmark., Czaja TP; Department of Food Science, Faculty of Science, University of Copenhagen, DK-1958 Frederiksberg, Denmark.; Department of Chemistry, University of Wrocław, 50-383 Wrocław, Poland., van den Berg FWJ; Department of Food Science, Faculty of Science, University of Copenhagen, DK-1958 Frederiksberg, Denmark., Jespersen BM; Department of Food Science, Faculty of Science, University of Copenhagen, DK-1958 Frederiksberg, Denmark., Larsen KL; Section of Chemistry, Department of Chemistry and Bioscience, Aalborg University, DK-9220 Aalborg, Denmark.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2021 Apr 13; Vol. 26 (8). Date of Electronic Publication: 2021 Apr 13.

Long wavelength near-infrared transmission spectroscopy of barley seeds using a supercontinuum laser: Prediction of mixed-linkage beta-glucan content.

Autor: Ringsted T; Department of Food Science, University of Copenhagen, Frederiksberg, Denmark. Electronic address: tine.ringsted@food.ku.dk., Ramsay J; Department of Chemistry, Aarhus University, Aarhus, Denmark. Electronic address: jacob.ramsay@chem.au.dk., Jespersen BM; Department of Food Science, University of Copenhagen, Frederiksberg, Denmark. Electronic address: bm@food.ku.dk., Keiding SR; Department of Chemistry, Aarhus University, Aarhus, Denmark. Electronic address: keiding@chem.au.dk., Engelsen SB; Department of Food Science, University of Copenhagen, Frederiksberg, Denmark. Electronic address: se@food.ku.dk.

Publikováno v: Analytica chimica acta [Anal Chim Acta] 2017 Sep 15; Vol. 986, pp. 101-108. Date of Electronic Publication: 2017 Jul 12.

Identification of weak and gender specific effects in a short 3 weeks intervention study using barley and oat mixed linkage β-glucan dietary supplements: a human fecal metabolome study by GC-MS.

Autor: Trimigno A; Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark.; Department of Agricultural and Food Sciences, Alma Mater Studiorum - University of Bologna, Piazza Goidanich 60, 47521 Cesena (FC), Italy., Khakimov B; Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark., Mejia JLC; Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark., Mikkelsen MS; Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark., Kristensen M; Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark., Jespersen BM; Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark., Engelsen SB; Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C, Denmark.

Publikováno v: Metabolomics : Official journal of the Metabolomic Society [Metabolomics] 2017; Vol. 13 (10), pp. 108. Date of Electronic Publication: 2017 Aug 18.

Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI.

Autor: Blaabjerg M; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Ruprecht K; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Sinnecker T; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Kondziella D; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Niendorf T; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Kerrn-Jespersen BM; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Lindelof M; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Lassmann H; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Kristensen BW; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Paul F; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense., Illes Z; Departments of Neurology (M.B., Z.I.) and Pathology (B.W.K.), Odense University Hospital, Denmark; Clinical and Experimental Multiple Sclerosis Research Center (K.R., T.S., F.P.), Department of Neurology (K.R., F.P.), NeuroCure Clinical Research Center (T.S., F.P.), and Experimental and Clinical Research Center (T.N., F.P.), Charité-Universitätsmedizin Berlin, Germany; Department of Neurology (T.S.), Universitatsspital Basel, Switzerland; Department of Neurology (D.K.), Rigshospitalet, Copenhagen University Hospital, Denmark; Berlin Ultrahigh Field Facility (B.U.F.F.) (T.N.), Max Delbrueck Center for Molecular Medicine (F.P.), Berlin, Germany; Department of Neurology (B.M.K.-J., M.L.), Herlev Hospital, Denmark; Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Institute of Clinical Research (M.B., B.W.K., Z.I.), University of Southern Denmark, Odense.

Publikováno v: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2016 Apr 20; Vol. 3 (3), pp. e226. Date of Electronic Publication: 2016 Apr 20 (Print Publication: 2016).